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THE SEQUENTIAL SCHEDULE FOR POLIOVIRUS IMMUNIZATION: FACTORS ASSOCIATED
WITH ITS ADOPTION BY PRIMARY CARE PROVIDERS
Melissa S. Ellis, Philip LaRussa, Sally Findley, and Matilde Irigoyen. Department of Pediatrics, Columbia
University, New York, NY. (Sponsored by Eugene Shapiro, Department of Pediatrics, Yale University
School of Medicine, New Haven, CT).
Background and objectives: In January 1997 the Advisory Committee on Immunization Practices (ACIP)
recommended switching from, a schedule consisting solely of oral polio vaccine to a sequential one
consisting of both an inactivated, injectable vaccine and an oral vaccine. The objectives of this project
were to gain a better understanding of how providers learn about changes in immunization policy and to
identify factors that were important to them in deciding whether to adopt the sequential schedule.
Methods: Providers in Northern Manhattan were surveyed between July and August 1997. Data were
collected on the professional qualifications of the providers, their practice demographics, providers’
preferences for information sources, and their current polio immunization practices.
Results: 24% of providers had already adopted the sequential schedule, 40% were planning to adopt it, and
36% were not planning to adopt it. Compared with those who had no plans to switch, providers who either
had already switched or planned to switch were more likely to be members of the American Academy of
Pediatrics (AAP) (64.9% vs. 33.3%, p=0.021), to have a faculty appointment (75.7% vs. 42.9%, p=0.012),
and to prefer using MEDLINE (56.8% vs. 28.6%, p=0.039) or the “Red Book” (51.4% vs. 23.8%, p=0.041)
as sources of vaccination information. All providers identified similar factors that were important in their
vaccination decision making: compliance with ACIP, medical issues, personal judgment, and parental
concerns were considered more important than legal issues, logistic issues, and cost. When asked what
would make them switch to the sequential schedule, providers who were planning to adopt the sequential
schedule most commonly cited stronger recommendations by ACIP while those not planning to adopt cited
a legal mandate by the New York City Department of Health.
Conclusions: Providers who were not planning to adopt the sequential schedule were less likely to be
affiliated with an academic institution, to be AAP members, and to prefer the use of MEDLINE or the “Red
Book” for vaccination information. Our study identified a group of providers that would benefit from more
direct educational interventions to increase compliance with new vaccination practices.
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Introduction
In January of 1997, the Advisory Committee on Immunization Practices (ACIP)
recommended a change in the polio immunization schedule from a four-dose schedule of
orally-administered live-attenuated trivalent polio vaccine (OPV) to a sequential one
consisting of an enhanced potency inactivated polio vaccine (elPV) at 2 and 4 months
followed by OPV at 12-18 months and 4-6 years.1 The revised recommendations also
stated that an all-OPV or an all-elPV schedule met current standards of care for routine
childhood vaccination. While all three vaccination schedules were acceptable in offering
protection against paralytic polio, the sequential elPV/OPV schedule was preferable
because it could potentially reduce the number of cases of vaccine-associated paralytic
polio (VAPP) by fifty percent1 and still provide acceptable levels of intestinal immunity.
These recommendations were intended to aid in the transition towards the goal of
exclusive use of elPV during the subsequent three to five years.
In 1997, approximately five months after the recommendations for the sequential
schedule were published, we conducted a survey of pediatricians and other health care
providers in Northern Manhattan to assess their familiarity with the new
recommendations, their opinions about the changes, and their future intentions regarding
polio vaccination scheduling. The objectives of this project were (1) to gain a better
understanding of how health care providers learn about changes in immunization policy
(i.e., preferred sources of information) and (2) to identify factors that are important to
them in deciding whether to adopt the new recommendations. The goal of this project
was to gain insight into what motivates providers to implement changes in their current
vaccination practices.

Many studies have attempted to answer the question as to what motivates
physicians to change the way they practice medicine. One analysis in the literature
classified the methods of changing physicians’ practices into six general categories:
education, feedback, participation by physicians in efforts to bring about change,
administrative rules, financial incentives, and financial penalties.

While each method

has been shown to be effective on its own, interventions that rely on more than one
method generally have had the most success.

Based on the categorization presented

above, clinical practice guidelines pertaining to vaccination issues and vaccine
recommendations by professional organizations and committees, such as ACLP, are
considered forms of education. They are designed to inform providers about new
vaccines, new practices and/or those that meet current standards of care. Little is known
about how providers decide to implement changes in their practice methods once they
become aware of new guidelines. Overall, it has been found that clinical practice
guidelines have been remarkably unsuccessful in influencing physicians. ’

While no

studies have investigated the efficacy of ACIP vaccination recommendations to influence
change in physicians’ practice, given the similarities between such recommendations and
practice guidelines, it is likely that both share the same low level of success in changing
physicians’ behaviors.
Various barriers to compliance have been identified to explain the lack of success
of clinical practice guidelines among providers, including a lack of awareness of,
agreement with, and familiarity with the guidelines; lack of outcome-expectancy (i.e., the
expectation that a given behavior will lead to a particular consequence); inertia of
previous practice (i.e., no motivation to change); and external barriers (e.g., perception
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that patients fear additional injections).

In this study we identified factors that providers

consider important when deciding to change their vaccination practices and that correlate
with increased compliance with the new recommendations for polio immunization. In
light of the ongoing changes in polio vaccination recommendations and the certainty that
there will be more changes in the childhood immunization schedule in the future, the
lessons learned from this study may be utilized to develop more effective means of
disseminating new recommendations and to identify groups that should be especially
targeted for interventions to improve compliance with such recommendations.

Methods
We attempted to identify all providers in the study area with M.D. degrees who
regularly cared for children and who administered routine childhood vaccinations in
outpatient settings. Our study area consisted of neighborhoods north of 96th Street on the
west side of Manhattan. We compiled a list of all providers that we could identify from a
variety of sources including health plan directories from H.M.O.s that serve Northern
Manhattan, the Yellow Pages, the fellowship directories of the American Academy of
Pediatrics of New York, a list of participating providers in the Vaccines for Children
program, and staff rolls of the New York Presbyterian, Harlem, and St. Luke's-Roosevelt
Hospitals.
While the majority of questionnaires were administered in person, some providers
chose to be interviewed by telephone. In both settings, the provider had a copy of the
questions so that he or she could follow along while the interviewer verbally
administered the questionnaire. All answers were recorded by the interviewer. The
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questionnaire was administered during July and August of 1997. It consisted of 46
questions, required about 20 minutes to complete, and addressed three major issues:
(1) providers' preferences for information sources,
(2) awareness of and opinions about the recommended changes in the polio immunization
schedule,
(3) current polio immunization practices and plans for the future.
We also gathered demographic data on the providers who completed the questionnaire.
Part one consisted of questions of two types: open-ended questions and forced
choice questions with the opportunity to include additional responses. Providers selected
from a list of 21 different types of information sources (including MEDLINE and other
online sources, paper journals, Grand Rounds, the “Red Book” [Report of the Committee
on Infectious Diseases, American Academy of Pediatrics], printed material from
manufacturers, etc.) for information on immunization practices and changes in
vaccination recommendations. They were then asked in an open-ended format what their
top three preferred sources were for vaccination information.
In part two, providers were asked in an open-ended format if they were familiar
with the debate about the changes in the polio immunization recommendations and what
their opinion was about this. In part three, providers were asked in an open-ended format
what their current vaccination schedule was, if they were planning to change their
schedules in the future, what factors they considered when deciding on their schedule,
and, if they had not yet switched to an elPV-containing schedule, what it would take to
get them to do so in the future.
Responses were stratified into two groups based on their polio immunization
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practices: either (1) already adopted and planning to adopt or (2) not planning to adopt
the sequential elPV/OPV schedule. The statistical significance of differences between
proportions was assessed with the Chi-square test. Odds ratios, 95% confidence
intervals, and Chi-square tests were performed using STATXACT (Cytel Software,
Cambridge, Massachusetts). P values < 0.05 were considered statistically significant.
The initial idea for this project was devised by Dr. LaRussa, Dr. Findley, and Dr.
Irigoyen. They had already compiled a preliminary list of providers in the study area
when I started to work on this project. I developed the questionnaire under their
guidance, finalized the list of providers in the study area, and then contacted and
interviewed all of the providers. The preliminary statistical analyses of the data were
done by Dr. Findley. I then finalized the data using the STATXACT program under the
direction of Dr. Shapiro.

Results
We identified 94 providers in our study area. Twenty-two of these providers did
not take care of children or had recently moved out of the target area. Therefore, the total
number of eligible providers for this study was 72.
Of the 72 eligible providers, 58 (81%) agreed to complete the questionnaire.
Providers surveyed in this study had practices located in either of two Northern
Manhattan neighborhoods: Washington Heights/In wood, a predominantly Latino
community, and West Harlem, a predominantly African-American community which has
recently had an influx of both Latino and African immigrants. Both communities are
marked by high levels of poverty and low levels of vaccination coverage. Providers

6

deliver care in a variety of settings, such as private practices, community-based clinics
run by H.M.O.s, and hospital-based clinics.
Current practice regarding polio vaccination schedule: While all of the
providers surveyed in our study were familiar with the ACIP recommendations
concerning the sequential schedule, 24% had already adopted the sequential schedule,
40% were using an all-OPV schedule but were planning to adopt the sequential one, and
36% were using an all-OPV schedule and were not planning to switch. Adoption/planned
adoption of the sequential schedule was associated with membership in the American
Academy of Pediatrics (AAP) (64.9% vs. 33.3%; OR=3.69; 95% CI=1.19-11.44;
p=0.021) and faculty appointment (75.7% vs. 42.9%; OR=4.15; 95% 0=1.32-13.04;
p=0.012). Foreign birth, foreign medical school education, board certification, post¬
graduate fellowship, and active teaching duty were not significantly associated with
adoption of the sequential schedule (table 2).
Information sources: Of the 21 possible information sources presented as
choices in the questionnaire, physicians most commonly identified the following as their
preferred vaccination information sources: peer-reviewed publications, MEDLINE,
educational materials from manufacturers, recommendations from advisory committees,
the “Red Book,”and AAP Alerts (table 3). Other information sources that were less
commonly cited included text books, free publications, consults with other physicians,
continuing medical education courses, and Grand Rounds. Providers who had either
already adopted or planned to adopt the sequential schedule were more likely than those
who were not planning to adopt the sequential schedule to have identified MEDLINE
(56.8% vs. 28.6%; OR=3.28; 95% <21=1.04-10.35; p=0.039) and the “Red Book” (51.4%
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vs. 23.8%; OR=3.38; 95% 0=1.02-11.14; p=0.041) as their preferred sources of
information. There was no difference in the use of the other commonly preferred
information sources among these two groups of providers.
We further defined the group of providers who identified MEDLINE as their
preferred source for vaccination information. While there was no statistically significant
association between reported use of MEDLINE and AAP membership, MEDLINE users
were more likely than non-users to have faculty appointments (88.9% vs. 4.9%;
0R=11.08; 95% 0=2.74-44.76; p<0.001) and active teaching duty (26.0% vs. 0%; OR
and 95% Cl undefined; p=0.003) (table 4).
Important factors in decision-making: We asked providers to specify which
factors were important in their decision making when choosing a polio immunization
schedule (table 5). Almost all providers indicated that compliance with ACIP
recommendations was important. While there were no significant differences in the
frequencies of the listed factors among those who did and those who did not adopt the
sequential schedule, medical issues (e.g., confidence in vaccine efficacy trials, risk of
VAPP, herd immunity), personal judgment, and parental concerns were more commonly
cited by all providers than legal issues, logistic issues (e.g., availability of staff to
administer additional injections), and cost.
In a separate question, providers who had already adopted and those who were
planning to adopt the sequential schedule were asked to identify the most important
factors that affected their decision to switch to the new schedule. The most commonly
cited factors by all providers were (1) reduction in the risk of VAPP and (2) compliance
with ACIP (table 6). Other, less commonly cited factors included maintenance of
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intestinal immunity, fear of liability for VAPP, and safety issues for HTV-positive and
immunocompromised recipients. For providers who had already adopted the sequential
schedule, the difference between the importance of reducing the risk of VAPP (78.6%)
compared to that of complying with ACIP recommendations (14.3%) when making their
decision to adopt the sequential schedule was statistically significant (p<0.001). This
difference was not statistically significant for providers who were planning to adopt the
sequential schedule.
Finally, providers who had not switched schedules at the time that the survey was
administered (those planning to switch who had not done so yet and those with no plans
to switch) were asked what it would take to get them to make the switch (table 7). Five
motivating factors were most commonly identified: stronger recommendations by ACIP,
legal mandate from the New York City Department of Health, availability of combination
vaccines containing elPV to reduce the number of injections required per visit, evidence
that elPV is more effective than OPV, and exhaustion of their current OPV supply. Other
factors that were less commonly cited by providers included: an increase in the number of
cases of VAPP per year, endorsement of the schedule by other physicians, use of elPV by
the World Health Organization, and a decrease in elPV cost. Although the differences
were not statistically significant, providers who were planning to adopt the sequential
schedule more commonly indicated stronger recommendations by ACIP as a motivating
factor to switch schedules (30.4% versus 14.3% of providers not planning to adopt),
while providers not planning to adopt the sequential schedule more commonly indicated a
legal mandate (42.9% versus 21% of providers planning to adopt). Among the listed
factors, the only statistically significant difference between the two groups of providers
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was in the importance of availability of a combination vaccine, which was cited by 17.4%
of providers who were planning to switch schedules and by no providers who were not
planning to switch (OR and 95% Cl undefined; p=0.045).

Discussion
Background: There has been a dramatic decrease in the number of cases of
paralytic poliomyelitis since the introduction of IPV in 1955 and then OPV in the early
1960’s. The annual number of cases of paralytic polio reported in the United States has
declined from approximately 20,000 in 1952 to an average of 9 during the years of 19801991.4 The last indigenously acquired case in the United States was reported in 19795
and the Western Hemisphere was declared to be free of indigenous wild polio virus in
1994.6 Due to the large-scale efforts by the World Health Organization (WHO), polio
cases reported globally have decreased by more than 80% since the mid-1980’s. ’ ’

In

1988 the WHO resolved to eradicate poliomyelitis globally by the year 2000 and we are
now close to realizing this goal. ’

These remarkable achievements throughout the world

can be attributed to the almost exclusive use of OPV for routine childhood vaccination.
The first polio vaccine to be introduced was the inactivated polio vaccine by
Jonas Salk in 1955. It was replaced by oral live-attenuated trivalent polio vaccine in the
early 1960s. Developed by Sabin, OPV was favored in the United States for routine
immunization of children because of its ease of administration, expected long-lasting
immunity, and the production of intestinal immunity. Intestinal immunity is a major
advantage of OPV over IPV as it allows for fecal spread of the vaccine virus to
unimmunized contacts. It also provides protection against intestinal infection with wild
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virus thus limiting its spread to others. This has been regarded as an advantage of OPV
over IPV for inner-city children, who historically have had low vaccination rates10 and
are at the highest risk of acquiring wild polio from new immigrants. A new enhancedpotency inactivated polio vaccine (elPV) was introduced in 1988. While eEPV has been
shown to induce higher post-vaccination serum antibody levels, it is less effective than
OPV in preventing and limiting intestinal infection.11 In addition, the increased cost of
elPV and its mode of delivery, namely injection, has historically made this a less popular
choice in the United States compared with OPV.
Despite its almost exclusive use for routine poliovirus vaccination in this country
for many years, use of OPV is not without disadvantages. Each year approximately 8-9
cases of VAPP are reported.1 VAPP occurs as a consequence of the reversal of
attenuating mutations in the vaccine virus, potentially affecting recipients of OPV,
unvaccinated contacts of the recipient, or other unvaccinated members of the community
who are exposed to pathogenic revertant virus. While these molecular events may occur
frequently, they occur only rarely with adverse consequences.

The risk of acquiring

VAPP is approximately 1 case per 2.4 million total doses distributed or 1 case per
750,000 children receiving their first dose. ’

From 1980 to 1994, 133 confirmed cases

of paralytic poliomyelitis were reported. Of these, 6 cases were imported from outside
the US with only one occurring after 1986; 2 cases were considered indeterminate in
origin. The remaining 125 cases (94%) (annual mean: 8 cases) were classified as
vaccine-associated: 49 (39%) occurred among immunologically normal recipients of
OPV, 46 (37%) among immunologically normal people who were suspected contacts of
OPV recipients, and 30 (24%) among immunologically compromised OPV recipients or
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•

•

suspected contacts of OPV recipients.
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In light of the progress being made towards global polio eradication and the
ongoing risk of VAPP,14 in January 1997 the ACIP recommended a switch from an allOPV schedule to a sequential eLPV-OPV schedule for routine childhood immunization.
This recommendation was also endorsed by the American Academy of Pediatrics and the
American Academy of Family Physicians. Although the sequential schedule was
preferred, all-OPV or all-elPV schedules were also deemed acceptable. The logic behind
the sequential schedule was that the use of elPV for the first 2 doses would reduce the
incidence of VAPP by inducing sufficient serum neutralizing antibody to prevent
invasive infection on subsequent vaccination with OPV. By keeping OPV in the
schedule, children would still benefit from the advantages of OPV, namely intestinal
immunity and secondary spread of the vaccine virus. It was hypothesized that a switch in
this schedule would allow for a 50% decrease in the annual number of cases of VAPP.1
When the new recommendations were introduced, there were concerns that a
change in polio vaccination schedules would adversely affect vaccination rates because
of the increased cost of eEPV and the addition of another series of injections to childhood
vaccinations. However, studies have shown that there has been no associated decrease
during this time in the vaccination coverage of routinely recommended immunizations
for children.15 Based on the success of the sequential schedule and also the rapid
progress of the global polio eradication initiative, which decreases the likelihood of
poliovirus importation into the United States, ACEP has recommended that children
follow an all-elPV schedule starting on January 1, 2000 in an effort to fully eliminate the
risk of VAPP.16
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Present study: At the time that our study was conducted, approximately five
months after the introduction of the new recommendations in 1997, all of the providers
were familiar with the ACIP recommendations. However, only 24% of providers had
switched to the ACIP-preferred sequential schedule. Providers who were members of the
American Academy of Pediatrics and those who had an appointment at an academic
medical center were more likely to have adopted or to have been planning to adopt the
sequential schedule. This finding is intriguing because the American Academy of
Pediatrics did not favor one particular schedule but rather left the decision up to the
provider. The AAP made it clear that each of the three poliomyelitis vaccine schedules
(sequential efPV/OPV, all-elPV, or all-OPV) was highly effective and acceptable for
routine vaccination. To explain the finding that AAP members or providers with faculty
appointments at medical centers were more likely to have switched, one might
hypothesize that these two groups of physicians were better informed of the issues
involved by virtue of exposure to the educational efforts of the Academy and the
academic medical centers. Conversely, perhaps this demonstrates a process of selfselection in that those who are affiliated with either the AAP or an academic medical
center are well informed and more aware of current vaccination issues in general based
on their self-education practices.
While there are many possible hypotheses to explain the associations we found,
one interesting idea concerns the use of educational strategies to change physicians’
practices. While clinical guidelines, one form of education, have been shown to be
generally unsuccessful in changing physicians’ practices, providing such guidelines to
“opinion leaders” (people identified by physicians as highly regarded and trusted sources
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of information) has shown some promise in accomplishing this goal." For example, in
one study, the rate of cesarean sections was dramatically reduced when opinion leaders
were recruited, trained, and returned to their communities to educate their colleagues. In
a sense, providers who are affiliated with an academic medical center or with a
professional group are constantly surrounded by “opinion leaders,” such as the
departmental chairperson or leaders of a local AAP chapter. Once a consensus is reached
among a clinical department or professional society, it is common for providers affiliated
with these organizations to adopt the practices endorsed by the group leaders. While the
decision is ultimately up to the individual provider, in some sense the decision of whether
to adopt or not to adopt a new clinical practice is made by the leaders of the group at
large. This form of education is not available to some community providers who are not
part of a larger group, such as an academic department or professional society. They
have to reach their decisions on their own without the benefit of having “opinion
leaders.” While this is merely speculation, it would be interesting to further investigate
the utility and effect of opinion leaders on changing the practices of community
providers.
The top sources of vaccination information identified by providers included peer
reviewed publications, MEDLINE, educational materials from pharmaceutical
manufacturers, and recommendations from advisory committees. Other studies have
identified additional primary sources that providers prefer for vaccination-related
information, such as the AAP policy statement17and the “Red Book.”18 While we
identified an association between AAP members and adoption of the sequential schedule,
AAP policy statements and bulletins were not commonly identified as important sources
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for vaccination information. In our study, the use of the “Red Book” and of MEDLINE
were associated with switching to the sequential schedule. Given that the “Red Book” is
a reference published by the AAP and provided free to its members, the association of
increased adoption/planned adoption of the sequential schedule with use of the “Red
Book” mirrors the association of increased adoption with AAP membership. The
association of MEDLINE with increased adoption does not have as straightforward a
relationship. Perhaps through the use of MEDLINE these providers were able to stay
best informed of new information and to learn about the complex issues regarding VAPP
and the polio vaccination recommendations. Conversely, perhaps those who are better
informed of medical issues choose to use MEDLINE as a source of vaccination
information.
Several studies have demonstrated high rates of usage of MEDLINE by health
care professionals.19,20 When providers were asked why they preferred MEDLINE over
other sources of information they stated that MEDLINE offered current and specific
information, it was of low cost, and it was convenient.19 In our study, while there was no
significant association of MEDLINE usage and AAP membership, MEDLINE users were
more likely to have had faculty appointments and active teaching duty than non-users. It
is possible that those with faculty appointments have increased access to computers and
Internet services, thus explaining the association in our study of these providers and their
use of MEDLINE. However, further research is necessary to determine whether the
availability of these resources or the self-education practices of these physicians is most
important in determining how providers keep abreast of changes in immunization policy.
All providers identified similar factors that influenced their decision on which
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schedule to adopt. Medical issues, personal judgment, and parental concerns were more
commonly cited by all providers than legal issues, logistic issues, and cost. This is in
contrast to a study of providers in Ohio, which found that cost and liability were
significantly related to providers’ choices regarding which schedule they followed.
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Almost all providers in our study, including those who were not planning to adopt the
sequential schedules, indicated that compliance with ACIP recommendations was
important in making their decision regarding which schedule to adopt. While ACIP
preferred the sequential schedule, it allowed physicians to make their own choice among
the three vaccination schedules. The recommendations did not require a switch to one
particular schedule in order to meet current standards of care. Thus, if a provider was
unsure about switching schedules, he or she would have little impetus to make a switch
given the way the recommendation was presented. If in fact complying with ACIP is an
important factor when providers choose vaccination schedules, a strong recommendation
by ACIP could be an important way to affect vaccination practices. It will be interesting
to see whether the switch-over rate after January 1, 2000 to the all elPV schedule is
adopted more readily than previous recommendations since the new recommendations do
not allow the providers any options regarding alternate schedules.
Other studies have shown an association between physicians’ personal
experiences with a particular disease and their adoption of new vaccination practices.
Physicians who had first-hand experience with complications caused by varicella virus17
or Haemophilus influenzae type b

were more likely to have adopted vaccination

practices to protect against these diseases. For example, pediatricians who had seen a
death from varicella were far more likely to have recommended universal immunization
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as compared with those who had not seen such a devastating outcome of this disease.17
However, complications from the polio vaccine such as VAPP are exceedingly rare and
thus we cannot rely on physicians’ personal experience to impact on their decision to
adopt an elPV schedule.
Providers who had already adopted or were planning to adopt the sequential
schedule indicated the importance of reducing the risk of VAPP more often than of
complying with ACIP recommendations as the most important factor in choosing a
schedule. This pattern has been demonstrated in other studies as well, where compliance
with ACEP is not considered as important as medical issues when providers decide
whether or not to adopt new vaccination practices.17 One can deduce that most providers
do not readily comply with ACEP without considering the medical implications of new
vaccination practices.
At the time of our study, we identified two groups of providers who were still
using an all-OPV schedule: providers who had decided to switch schedules but had not
done so yet and those who had no plans to switch schedules. While both cohorts of
providers identified similar factors that would make them switch schedules, there was a
significant difference between the two groups in the importance ascribed to the
availability of a combination vaccine. Providers who had plans to adopt the sequential
schedule but had not done so yet indicated that the availability of an elPV-containing
combination vaccine to decrease the number of injections per visit was a key factor that
would motivate them to switch schedules. Several studies have investigated this finding
of negative reactions of health professionals towards the number of injections required
for routine vaccinations. These studies demonstrate the strong concerns of
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physicians, ’

often greater than those of parents, about children receiving more than 3

injections per visit. ’

A study by Mary Lou Thoms et al. demonstrated that 61.3% of

parents would chose to have their child receive elPV and three injections per visit as
compared with an all-OPV schedule

in order to reduce the risk of VAPP.

Although it

had been a concern that adding more injections per visit could have an adverse effect of
decreasing vaccination rates, this has not occurred for polio vaccination coverage with
the sequential efPV-OPV schedule.15 It is important to stress to providers that additional
injections are not regarded so negatively by parents as long as they feel that such practice
benefits the health of their children. Given the importance that providers ascribe to
reducing the number of injections per visit, the development and availability of
combination vaccines would be another way to avoid this barrier that is associated with
new vaccination practices requiring additional injections.
A large number of providers who had no plans to adopt the sequential schedule
indicated that a mandate from the Department of Health requiring a change in schedules
would be the only impetus for them to change their current practice. The importance of a
Department of Health mandate for these providers, who were less likely to be AAP
members or to have faculty appointments than providers who had plans to switch
schedules or those who had already done so, can be interpreted in light of the “opinion
leader” hypothesis presented above. The Department of Health is a respected and trusted
institution in the community to which providers look for guidance and instruction on
current health practices and standards of care. Much like a departmental chairperson or
AAP president who act as authorities or opinion leaders for providers affiliated with these
organizations, the Department of Health acts as the authority for providers in the
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community. Providers look to the Department of Health when making practice decisions
regarding controversial issues, such as adoption of the sequential polio vaccination
schedule. Although this is only speculation, the importance of this response is
noteworthy in that these providers have identified an agency, beyond ACIP and other
professional groups, which has the potential to influence providers’ choices and to
increase compliance for vaccination programs and schedules. Increased cooperation
between ACIP and the Department of Health along with more active involvement on the
part of the Department of Health in promoting vaccination recommendations could have
the potential to increase providers’ compliance with new recommendations.
Limitations of the study: One major limitation of our study was that we did not
directly question providers who had no plans to switch schedules about their perceived
barriers to adoption of the sequential schedule. Our questions focused more on which
factors were important when choosing the schedule that they currently used and less on
which factors were important when deciding not to switch to the sequential schedule.
Using our line of questioning, we were still able to gather some information about this,
for instance that cost and legal issues were not important when deciding on a schedule.
However, we cannot comment on the specific factors that kept them from switching
schedules.
Summary and conclusion: Although the number of providers surveyed in our
study was small, this group of 58 accounted for the majority of the physicians providing
care to children in Northern Manhattan. Within this group, 36% of the providers had no
plans to switch to the sequential schedule. While all the providers in our study indicated
familiarity with the recommendations, preferred similar sources for vaccination
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information, and shared similar demographic characteristics, providers who had no plans
to switch schedules were less likely to be affiliated with an academic institution or to be
members of the AAP. Our study identified a group of providers that would benefit from
more direct targeting to increase compliance with new vaccination practices. First, we
encourage ACIP and other committees to continue to extend their informational effort to
community providers who are not affiliated with either an academic institution or a
professional group such as the AAP. The circulation of vaccination recommendations in
a wide range of publications, such as the ones identified in our study, ensures adequate
exposure of new recommendations to a large segment of providers. Secondly, increased
cooperation of the Department of Health with ACIP could be one potential way to
encourage a change in vaccination practices for many of these providers who may look to
the Department of Health for guidance regarding such changes.
We also offer the following recommendations to increase overall compliance with
new vaccination recommendations among all providers in general. Given the
importance providers ascribe to complying with ACIP, providers may be more likely to
change their vaccination practices if ACIP introduces strong recommendations regarding
a specific schedule to follow. In the case of the sequential schedule, there appeared to be
less of an impetus to change schedules to an ACIP-preferred one when all three met
current standards of care and compliance with ACIP. While compliance with ACIP was
identified as an important factor when deciding on which schedule to use, the most
important factor concerned the risk of VAPP. Medical issues such as VAPP should
continue to be stressed when recommendations regarding new practices are introduced.
Providers are not as likely to blindly follow ACIP recommendations if they do not
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believe that they are medically important. Finally, providers’ reluctance to increase the
number of injections per visit is a barrier to new vaccination practices that involve
additional injections. As mentioned above, there are several ways to get around this
barrier, such as increasing the availability of combination vaccines and providing data
from studies that show that parents are not as averse to additional injections as providers
may believe.
The providers identified in our study serve a chronically under-immunized
segment of the pediatric population that by virtue of their close contact with immigrants
and visitors from countries where wild polio virus is still circulating, are at highest risk to
be infected if not adequately immunized, hi a community where vaccination rates of
children are not 100%, a switch by some providers to an all-elPV schedule, with its lack
of circulation of live virus vaccine from immunized to unimmunized children, will raise
the risk even further of possibly acquiring wild poliovirus. A primary goal for the future
is to ensure adequate vaccination for all children living in these communities. One way
to do this is to increase providers’ compliance with advisory recommendations in general.
Therefore the identification of sources of information used by providers and the factors
which motivate them to make choices regarding vaccination practices are critically
important. Continued research along these lines will help further to elucidate these
factors, to disseminate information more efficiently, and to increase compliance with
important vaccination recommendations.
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Table 1: Characteristics of Providers (N=58)
Age (mean)
Sex
Men
Women
Country of origin
Dominican Republic
Other Latin American countries
Asian countries
United States
Training
Graduate of non-US medical school
Completed pediatric residency training
Completed a fellowship
Board-certified
Years of post-graduate training (mean)
Medical center affiliation
Any faculty appointment
Active teaching duty
Member of American Academy of Pediatrics

50 years
71 %
29%
41 %
24%
20%
15 %
83%
85 %
45%
65 %
4.2 years
63 %
26%
53 %
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Table 2: Characteristics of Providers by Adoption of Sequential Schedule

Characteristic

Providers Who
Already
Adopted or
Planned To
Adopt (n=37)

Providers Who
Did Not Plan
To Adopt
(n=21)

Odds Ratio
(95%
Confidence
Interval)

P

83.8 %
78.4 %

95.2 %
81.0%

0.26 (0.03-2.31)
0.85 (0.22-3.26)

0.198
0.816

70.3 %
51.4%

57.1 %
33.3 %

1.77 (0.58-5.41)
2.11 (0.69-6.43)

0.312
0.185

64.9 %

33.3 %

3.69(1.19-11.44)

0.021*

75.7 %

42.9 %

4.15 (1.32-13.04)

0.012*

16.2%

4.8 %

4.14(0.46-37.01)

0.175

Foreign bom
Graduate of nonUS medical
school
Board-certified
Completed
fellowship
Member of
American
Academy of
Pediatrics
Any faculty
appointment
Active teaching
duty
statistically significant
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Table 3: Top Information Sources Preferred by Physicians for Vaccination
Information by Adoption of Sequential Schedule

Information
Source

Providers
Who Already
Adopted or
Planned To
Adopt
(n=37)

Providers Who
Did Not Plan
To Adopt
(n=21)

100%

Peer reviewed
publications
MEDLINE
Educational
materials from
manufacturers
Recommendations
from Advisory
Committees
(ACIP,
Department of
Health)
Red Book
AAP Alerts
statistically significant
+ undefined

100%

Odds Ratio
(95%
Confidence
Interval)
+

1.000

56.8 %
51.4%

28.6 %
66.7 %

3.28 (1.04-10.35)
0.53 (0.17-1.61)

0.039*
0.258

56.8 %

57.1 %

0.98 (0.33-2.90)

0.977

51.4%
24.3 %

23.8 %
9.5 %

3.38 (1.02-11.14)
3.05 (0.59-15.74)

0.041*
0.167

P
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Table 4: Affiliation of Providers by Use of MEDLINE

Characteristic
Member of the
American
Academy of
Pediatrics
Any faculty
appointment
Active teaching
duty

Uses
MEDLINE
(n=27)
66.7 %

Does Not Use
MEDLINE
(n=31)

Odds Ratio
(95%
Confidence
Interval)

P

45.2 %

2.43 (0.84-7.07)

0.100

88.9 %

41.9%

<0.001*

26.0 %

0%

11.08 (2.7444.76)
+

>jc

statistically significant
+ undefined

0.003*
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Table 5: Factors Influencing Decision-Making by Adoption of Sequential Schedule

Influential
Factor
Compliance with
ACIP
Medical issues
Personal
judgment
Parental concerns
Legal issues
Logistic issues
Cost

Providers Who
Already
Adopted or
Planned To
Adopt
(n=37)

Providers Who
Did Not Plan
To Adopt
(n=21)

97.3 %

100.0%

Odds Ratio
(95%
Confidence
Interval)
+

0.447

78.4 %
78.4 %

76.2 %
71.0%

1.13 (0.32-4.05)
1.45 (0.42-4.95)

0.848
0.552

62.2 %
54.1 %
24.3 %
18.9%

76.2
52.4
23.8
23.8

0.51
1.07
1.03
0.75

0.274
0.902
0.965
0.659

%
%
%
%

(0.15-1.71)
(0.37-3.13)
(0.29-3.61)
(0.20-2.74)

P

Note: totals for each column exceed 100% because providers could select more than one
factor.
+ undefined
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Table 6: Most Influential Factors Affecting Decision-Making by Adoption of
Sequential Schedule

Influential
Factor
Decrease risk of
VAPP
Compliance with
AGP
recommendations

Providers Who
Already
Adopted
(n=14)

Providers Who
Planned To
Adopt
(n=23)

Odds Ratio
(95%
Confidence
Interval)

P

78.6 %

52.2 %

3.36 (0.74-15.32)

0.108

14.3 %

34.8 %

0.31 (0.06-1.76)

0.173
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Table 7: Factors Cited As Motivating Change in Providers’ Practices by Adoption
of Sequential Schedule

Motivating
Factors
Stronger
recommendations
by ACIP
Legal mandate by
New York City
Department of
Health
Availability of
combination
vaccine
containing elPV
Evidence that
elPV is more
effective than
OPV
Exhaustion of
current OPV
supply

Providers Who
Planned To
Adopt
(n=23)
30.4 %

Providers Who
Did Not Plan
To Adopt
(n=21)

Odds Ratio
(95%
Confidence
Interval)

P

14.3 %

2.63 (0.58-11.90)

0.202

21.7%

42.9 %

0.37 (0.10-1.38)

0.133

17.4%

0%

+

0.045*

13.0%

19.0%

0.64 (0.13-3.26)

0.587

13.0%

0%

+

0.086

statistically significant
+ undefined
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